Roivant Sciences Stock Price, News & Analysis

roivw

Company Description

Roivant Sciences (Nasdaq: roivw) is a publicly traded company.

roivw stock has gained 472.3% over the past year.

This page provides a comprehensive overview of roivw stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

+472.32%

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

Roivant Sciences (roivw) stock. Over the past 12 months, the stock has gained 472.3%.

Latest News

View All

9 days ago

0.00%

Roivant Announces Genevant Sciences’ and Arbutus Biopharma’s $2.25 Billion Global Settlement With Moderna

9 days ago

0.00%

Priovant Announces FDA Acceptance and Priority Review of New Drug Application for Brepocitinib in Dermatomyositis

clinical trial

February 6, 2026

0.00%

Priovant Announces Positive Phase 2 Results for Brepocitinib in Cutaneous Sarcoidosis (CS)

clinical trial

February 6, 2026

0.00%

Roivant Announces Positive Phase 2 Results for Brepocitinib in Cutaneous Sarcoidosis (CS) and Reports Financial Results for the Third Quarter Ended December 31, 2025

earnings clinical trial

January 23, 2026

0.00%

Roivant to Report Financial Results for the Third Quarter Ended December 31, 2025, and Provide Business Update on Friday, February 6, 2026

earnings date

December 11, 2025

0.00%

Roivant Highlights Continued Pipeline Progress and Outlook for Company’s Next Phase of Growth at 2025 Investor Day

Roivant Sciences has 10 recent news articles. Key topics include clinical trial, earnings, earnings date, conferences. View all roivw news →

SEC Filings

View All

No SEC filings available for roivw.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months